JPMORGAN CHASE & CO

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Back to ARWR Full portfolio

Position in ARWR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$51,954,389

+$9,126,029 QoQ

Shares Held

637,399

-6.7% QoQ

Ownership

0.451%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 497 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. ARWR ranks #30 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

All Filings in ARWR

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,954,389	637,399	-6.7%	Shares	Defined	2026-08-12
2026-03-31	$42,828,360	683,068	+11.6%	Shares	Defined	2026-05-13
2025-12-31	$40,624,701	611,910	-21.1%	Shares	Defined	2026-02-11
2025-09-30	$26,754,478	775,717	+90.3%	Shares	Defined	2025-11-07
2025-06-30	$6,440,773	407,644	-16.4%	Shares	Defined	2025-08-12
2025-03-31	$6,212,925	487,671	-75.9%	Shares	Defined	2025-05-12
2024-12-31	$37,984,006	2,020,426	-6.0%	Shares	Defined	2025-02-12
2024-09-30	$41,614,600	2,148,405	-7.2%	Shares	Defined	2024-12-26
2024-06-30	$60,185,169	2,315,705	-12.2%	Shares	Defined	2024-12-26
2024-03-31	$75,448,599	2,638,063	-4.1%	Shares	Defined	2024-12-26
2023-12-31	$84,182,067	2,751,048	-1.2%	Shares	Defined	2024-12-26
2023-09-30	$74,781,841	2,783,098	-3.4%	Shares	Defined	2023-11-14
2023-06-30	$102,733,391	2,880,914	-1.0%	Shares	Defined	2023-08-11
2023-03-31	$73,913,110	2,909,965	+3.2%	Shares	Defined	2023-05-18
2022-12-31	$114,412,538	2,820,822	-2.5%	Shares	Defined	2023-02-13
2022-09-30	$95,597,817	2,892,521	-3.3%	Shares	Defined	2022-11-14
2022-06-30	$105,306,595	2,990,815	+2.4%	Shares	Defined	2022-08-11
2022-03-31	$134,334,624	2,920,953	-2.0%	Shares	Other	2022-05-11
2021-12-31	$197,511,941	2,979,064	+4.9%	Shares	Defined	2022-02-11
2021-09-30	$177,253,875	2,839,242	+7.3%	Shares	Defined	2021-11-12
2021-06-30	$219,145,444	2,646,045	+2.8%	Shares	Other	2021-08-12
2021-03-31	$170,610,456	2,572,922	+6.8%	Shares	Defined	2021-05-12
2020-12-31	$184,890,985	2,409,631	+64.3%	Shares	Defined	2021-02-19
2020-09-30	$63,152,613	1,466,619	+248.9%	Shares	Defined	2020-11-12
2020-06-30	$18,152,927	420,304	+1.5%	Shares	Defined	2020-08-11
2020-03-31	$11,908,965	413,937	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.